Ads for brands including #Adobe, #GileadSciences, the University of Maryland’s football team, New York University Langone Hospital and NCTA-The Internet and Television Association were run alongside tweets from the account that had garnered hundreds of thousands of views, CNN observed https://www.cnn.com/2023/08/16/tech/x-ads-pro-nazi-account-brand-safety/index.html
#adobe #gileadsciences #musk #usa #news #x #twitter
Biogen, Novartis, Sanofi Cull Candidates in Q1 Pipeline Reprioritizations —After FDA rejection, Gilead nears full EU nod for hep D drug — Judge orders J&J, talc opponents to engage in settlement talks -- See more on our front page news http://bit.ly/w28kSd #earnings #biogen #novartis #sanofi #gileadsciences #hepatitisd #legal #bankruptcy #jnj #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#earnings #biogen #novartis #Sanofi #gileadsciences #hepatitisd #legal #bankruptcy #jnj #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Pfizer's Biohaven bet pays off again as migraine nasal spray wins approval— Moderna looks to the West Coast for latest expansion — Gilead gets big $175m judgment in HIV fraud case-- See more on our front page news http://bit.ly/w28kSd #pfizer #fda #migraines #moderna #westcoast #seattle #expansion #gileadsciences #hiv #fraud #legal #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#pfizer #FdA #migraines #moderna #westcoast #seattle #expansion #gileadsciences #hiv #fraud #legal #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Nektar's bitter pill: Phase 2 fail ends Lilly-partnered lupus program— Jounce slashes 57% of staff, drops assets in stock merger with Redx —GSK's ViiV says study shows its long-acting HIV shot as effective as Gilead's daily pill-- See more on our front page news http://bit.ly/w28kSd #nektartherapeutics #clinicaltrials #elililly #lupus #layoffs #reversemerger #hiv #gsk #gileadsciences #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#nektartherapeutics #clinicaltrials #elililly #lupus #layoffs #reversemerger #hiv #gsk #gileadsciences #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Moderna's cancer vaccine wins an FDA boon, but shares drop on mixed earnings— Graphite Bio cuts sickle cell therapy, half of staff —Gilead Sciences reports positive data from HIV therapy trial-- See more on our front page news http://bit.ly/w28kSd #moderna #vaccines #fda #mrna #cancer #earnings #layoffs #gileadsciences #hiv #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#moderna #vaccines #FdA #mrna #cancer #earnings #layoffs #gileadsciences #hiv #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma #clinicaltrials
BioNTech buys UK AI start-up InstaDeep in £562mn deal — JPM23: Gilead, Takeda, Pfizer, Moderna and more —The Big Three PBMs’ 2023 formulary exclusions: observations on insulin, Humira, and biosimilars -- See more on our front page news http://bit.ly/w28kSd #biontech #artificialintelligence #ai #mergersandacquisitions #jpm23 #jpm2023 #pfizer #moderna #takeda #gileadsciences #formulary #humira #pbms #biosimilars #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#biontech #artificialintelligence #ai #mergersandacquisitions #jpm23 #jpm2023 #pfizer #moderna #takeda #gileadsciences #formulary #humira #pbms #biosimilars #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
FDA Approves New HIV Drug for Adults with Limited Treatment Options | #FDA #NewDrugApproval #GileadSciences #lenacapavir #Sunlenca #HIV
#FDA #newdrugapproval #gileadsciences #lenacapavir #sunlenca #hiv
Kite swoops in to buy CAR-T company Tmunity — Roche takes over development of Biogen-partnered lymphoma drug — Biotech's key upcoming clinical results -- See more on our front page news http://bit.ly/w28kSd #kitepharma #gileadsciences #mergersandacquisitions #cart #roche #biogen #lymphoma #biotech #clinicaltrials #biotechnology #biopharma #pharma #pharmanews #cafepharma
#kitepharma #gileadsciences #mergersandacquisitions #cart #roche #biogen #lymphoma #biotech #clinicaltrials #biotechnology #biopharma #pharma #pharmanews #cafepharma